Insider Trading & Ownership of FRANK KARBE

Location: Brisbane, CA
Summary: The estimated net worth of FRANK KARBE is at least $6,044,872 dollars as of 07 Jan 2026. FRANK KARBE is the Principal Fin'l & Accounting of Myovant Sciences Ltd. and owns shares of Myovant Sciences Ltd. stock worth about $5.73M. FRANK KARBE is the Director of Phathom Pharmaceuticals, Inc. and owns shares of Phathom Pharmaceuticals, Inc. (PHAT) stock worth about $223.4K. FRANK KARBE is the Chief Executive Officer, Director of Better Therapeutics, Inc. and owns shares of Better Therapeutics, Inc. stock worth about $89.5K.
Signature: /s/ Shane Ward, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when FRANK KARBE files a new Insider Trading report.

Ownership of FRANK KARBE

Symbol	Company	Relationship	Holdings Value	Report Period
MYOV	Myovant Sciences Ltd.	Principal Fin'l & Accounting	$5,731,992	07 Jul 2021
PHAT	Phathom Pharmaceuticals, Inc.	Director	$223,425	03 Jun 2025
BTTX	Better Therapeutics, Inc.	Chief Executive Officer, Director	$89,455	18 Dec 2023
CDTX	Cidara Therapeutics, Inc.	Chief Financial Officer	$0	07 Jan 2026

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.